OLANZAPINE ODT TEVA ® 5 MG

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

OLANZAPINE 5 MG

Pieejams no:

SALOMON,LEVIN & ELSTEIN LTD

ATĶ kods:

N05AH03

Zāļu forma:

TABLETS ORODISPERSIBLE

Ievadīšanas:

PER OS

Ražojis:

TEVA OPERATIONS POLAND SP.ZO.O

Ārstniecības grupa:

OLANZAPINE

Ārstēšanas norādes:

Acute and maintenance treatment of schizophrenia. Olanzapine ODT Teva is indicated for the management of the manifestations of psychotic disorders. Olanzapine ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanzapine ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanzapine ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Autorizācija datums:

2011-05-01